The pharmaceutical giant Johnson & Johnson took a step forward with its COVID-19 vaccine candidate Thursday, releasing promising data after testing on monkeys and at the same time announcing the start of clinical testing on humans.
The pharmaceutical giant Johnson & Johnson took a step forward with its COVID-19 vaccine candidate Thursday, releasing promising data after testing on monkeys and at the same time announcing the start of clinical testing on humans.